Perry D. Nisen
- Neurology top 2%
- Neuroblastoma Research and Treatments 10
- Oncology top 5%
- Cancer-related Molecular Pathways 11
- Cancer Research top 5%
- Molecular Biology top 5%
- Renal and related cancers 9
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 4
- Genetics top 5%
- Virus-based gene therapy research 7
- Glioma Diagnosis and Treatment 5
-
- Immune Response and Inflammation 4
- Co-authors
- Anna BagnatoBruno BattistiniJoel B. NelsonPamela WaberFrederick W. AltRonald A. DePinhoNancy E. KohlEdith Legouy
- Cited by
- NeurologyOncologyCancer Research
- Journals
- Nature (2 papers)New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Perry D. Nisen
54 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 109
- Neurology 507
- Oncology 870
- Cancer Research 455
- Molecular Biology 1.8k
- Genetics 491
Countries citing papers authored by Perry D. Nisen
This map shows the geographic impact of Perry D. Nisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry D. Nisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry D. Nisen more than expected).
Fields of papers citing papers by Perry D. Nisen
This network shows the impact of papers produced by Perry D. Nisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry D. Nisen. The network helps show where Perry D. Nisen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Perry D. Nisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 1 | |
| 2 | 2000 | 11 | |
| 3 | 1997 | 42 | |
| 4 | 1996 | 32 | |
| 5 | 1996 | 56 | |
| 6 | 1996 | 62 | |
| 7 | 1995 | 49 | |
| 8 | 1995 | 14 | |
| 9 | 1993 | 31 | |
| 10 | 1993 | 30 | |
| 11 | 1993 | 11 | |
| 12 | 1991 | 2 | |
| 13 | 1991 | 6 | |
| 14 | 1990 | 2 | |
| 15 | 1990 | 32 | |
| 16 | 1990 | 22 | |
| 17 | 1989 | 35 | |
| 18 | 1988 | 6 | |
| 19 | 1988 | 80 | |
| 20 | 1977 | 62 |
About Perry D. Nisen
Perry D. Nisen is a scholar working on Neurology, Genetics and Oncology, having authored 55 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Neuroblastoma Research and Treatments (10 papers), Renal and related cancers (9 papers), Virus-based gene therapy research (7 papers), Glioma Diagnosis and Treatment (5 papers), Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Neurology (507 citations), Oncology (870 citations) and Cancer Research (455 citations). Perry D. Nisen has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Anna Bagnato, Bruno Battistini, Joel B. Nelson, Pamela Waber, Frederick W. Alt, Ronald A. DePinho, Nancy E. Kohl, Edith Legouy, Abeba Tesfaye and Kathryn A. Zimmerman. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.